We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ONC.LSE

Price
1.14
Stock movement up
+- (%)
Company name
Oncimmune Holdings plc
Exchange
(LSE
,
Currency
GBX
)
Sector
Healthcare >
Biotechnology
Market cap
127.42M
Ent value
133.73M
Price/Sales
26.73
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-93.67%
3 year return
-79.95%
5 year return
-53.15%
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

ONC.LSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales26.73
Price to Book-
EV to Sales28.05

FINANCIALS

Per share

Per share data
Current share count111.77M
EPS (TTM)-0.02
FCF per share (TTM)-0.14

Income statement

Income statement data
Revenue (TTM)4.77M
Gross profit (TTM)606.00K
Operating income (TTM)-9.54M
Net income (TTM)-1.64M
EPS (TTM)-0.02
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)12.71%
Operating margin (TTM)-200.04%
Profit margin (TTM)-34.49%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash911.00K
Net receivables1.96M
Total current assets3.23M
Goodwill1.58M
Intangible assets437.00K
Property, plant and equipment0.00
Total assets5.95M
Accounts payable1.78M
Short/Current long term debt5.26M
Total current liabilities2.85M
Total liabilities7.22M
Shareholder's equity-1.28M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-11.48M
Capital expenditures (TTM)402.00K
Free cash flow (TTM)-10.37M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-27.64%
Return on Invested Capital561.09%
Cash Return on Invested Capital3539.93%

STOCK INFORMATION

Stock chart

Stock price data
Open1.14
Daily high1.14
Daily low1.14
Daily Volume0K
All-time high254.00
1y analyst estimate50.00
Beta1.26
EPS (TTM)-0.02
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
ONC.LSES&P500
Current price drop from All-time high-99.55%-7.47%
Highest price drop-99.55%-56.47%
Date of highest drop17 Mar 20259 Mar 2009
Avg drop from high-43.69%-11.07%
Avg time to new high62 days12 days
Max time to new high993 days1805 days
COMPANY DETAILS
ONC.LSE (Oncimmune Holdings plc) company logo
Marketcap
127.42M
Marketcap category
Small-cap
Description
Oncimmune Holdings plc, a precision medicine company, provides autoantibody biomarker profiling in immuno-oncology, autoimmune, and infectious diseases in Europe and internationally. It offers ImmunoINSIGHTS, an autoantibody profiling service that unlocks the immune system to discover and convert autoantibodies into actionable biomarkers; Sero Tag, a discovery engine which identifies relevant biomarker pool for target discovery or companion diagnostics; NavigAID, a creation of a disease-specific biomarker panel; and Autoantibody Biomarkers, a companion diagnostic biomarker. The company also provides business development and marketing services. Oncimmune Holdings plc was incorporated in 2015 and is headquartered in Leeds, the United Kingdom.
Employees
38
Website
https://www.oncimmune.com
Investor relations
-
SEC filings
ONC.LSE SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved